The effect of some halogen-substituted flavanoids (dichloroflavan, halogenated isoflavans, and isoflavenes) on poliovirus type 2 infection was examined. Only two isoflavenes exhibited a significant inhibitory activity on the virus-induced cytopathic effect and plaque formation. In a single cycle of viral replication, both compounds reduced the viral yield by approximately 90%. The presence of the isoflavenes from the beginning of infection or during the adsorption period only prevented the shutoff of host translation and viral RNA and protein synthesis, suggesting that the drugs blocked an early step of viral replication. Indeed, both isoflavenes were not virucidal, did not protect virus infectivity from heat inactivation, and had no measurable effect on the binding of virus to cells, viral penetration, and uncoating of the viral RNA. In contrast, both compounds significantly reduced the infectivity of free viral RNA. The possibility that compounds interfere with poliovirus replication at a very early stage of translation of the input RNA is discussed.
Halogenated isoflavans and 3(2H)-isoflavenes are two series of analogs related to dichloroflavan (2) which possess in vitro antirhinovirus activity, although lower than that of dichloroflavan (4) , and anti-hepatitis A virus activity (13) .
Studies of the mechanism of action indicated that these compounds interfere with the early stages of rhinovirus (HRV) (6) and hepatitis A virus (HAV) (13) replication without impairing the viral binding to the cell membrane. Dichloroflavan was also seen to possess a strong inhibitory effect on the early events of HRV (14, 15) and HAV (13) multiplication, whereas it was found to be inactive on poliovirus type 1 infection (2). However, the possible effect on other types of poliovirus has not yet been described.
The aim of the present study was to evaluate the effectiveness of dichloroflavan, halogenated isoflavans, and isoflavenes on poliovirus type 2 infection. The compounds were tested on Sabin and wild type 2 (P712), reference strains, and on three type 2 Sabin-like revertants isolated from paralytic patients. The most active drugs were 3(2H1)-isoflavene (referred to herein as compound 3a) and 6-chloro-3(2H)-isoflavene (compound 3b). The mechanism of action of both analogs was examined in more detail to clarify at which level they interfere with picornavirus replication, and in this paper we report that the compounds were able to inhibit the replication cycle initiated by purified viral RNA. Kinetic studies suggest that they may interfere at a very early stage of translation of the input RNA.
MATERIALS AND METHODS
Compounds. The halogenated isoflavans (compounds 4a through d) and 3(2H)-isoflavenes (compounds 3a through g) (Fig. 1A ) were synthesized as previously described (4); compounds 3b, 4b (7) , and 3c (3) were already synthesized by other methods. Stock solutions in ethanol at 1 mg/ml were stored at 4°C before the dilution with tissue culture medium to run Plaque reduction assay. HEp-2 cell monolayers grown on 35-mm dishes were infected with 0.2 ml of virus dilution containing approximately 100 PFU. After adsorption (1 h at 37°C), the excess virus was removed, and the monolayers were overlaid with 2 ml of MEM containing 2% fetal calf serum, 1% agar, and the test compounds. The incubation was performed at 37°C in a humidified atmosphere of 5% CO2 in air. After 48 h, the cells were stained with 0.01% neutral red, and the plaques were counted.
Effect on virus yield. Monolayers of HEp-2 cells were infected with poliovirus type 2 (P712) (10 PFU per cell) in the presence of each compound for 30 min at 37°C. After the viral inoculum was washed out, fresh medium with the drugs was added. After 7 h of incubation at 37°C, infected cultures were freeze-thawed three times, and the titer of virus in the clarified supernatants was determined by plaque assay after extraction with chloroform to eliminate the antiviral compound.
Determination of viral and cellular protein synthesis. HEp-2 cell monolayers in 35-mm dishes were infected at an MOI of 10 PFU per cell with poliovirus type 2 (P712) and incubated for 30 min at 37°C. The inoculum was removed, and methionine-free medium was added. After 90 min of incubation at 37°C, the medium was replaced with fresh methionine-free medium containing 40 ,uCi/ml of [35S]methionine (1, 072 Ci/mmol; Amersham International). At the times indicated in the figure legends, monolayers were washed three times with PBS, and the cells were lysed with 0. 
RESULTS
Cytotoxcity and effect of compounds on viral plaque formation and CPE. The cytotoxicity of dichloroflavan and of the halogenated isoflavans (compounds 4a through d) and isoflavenes (compounds 3a through f) for HEp-2 cells was determined by measuring the effects produced on cell morphology and cell growth. The highest. amounts of each drug that did not cause any alteration of cell morphology, such as swelling, granularity, rounding, or floating, over a 3-day period are reported in Table 1 . At the indicated concentrations the viability of cells, as monitored by neutral red uptake, was unaffected. The maximum concentrations of each substance which did not affect the cell growth rate over a 3-day exposure period were 2 to 4 times lower than those previously noticed by morphological examination of cells (Table 1 ).
The ability of dichloroflavan, halogenated isoflavans, and isoflavenes to inhibit multiple cycles of virus replication was studied by measuring the effects. produced on the formation of plaques and on the development ofthe viral CPE in HEp-2 cells.
To investigate the influence on virus plaque formation, the drugs at 10 ,uM were incorporated into the agar overlay of infected cultures. Compounids 3a and 3b were the most active compounds, reducing the plaque formation by all poliovirus strains tested ( (Fig. 1B) decreased significantly (by 60%) (Fig. 2A) . The addition of compounds 3a and 3b at 20 puM from the beginning of infection prevented the shutoff of cellular protein synthesis. The same inhibitory effect was observed when compounds were present only during the viral adsorption period (30 min, 37°C). The addition of the inhibitors 30 min after adsorption or later had a negligible effect on the shutoff.
Poliovirus protein synthesis in the presence of different concentrations of compounds 3a and 3b was analyzed by SDS-polyacrylamide gel electrophoresis (Fig. 2B and C) .
The labeling of the viral proteins was normal when drugs were present up to 2 ,uM (Fig. 2, lanes d, d', e, e', f, and f'), whereas it was partially reduced at 10 ,uM (lanes g and g'). At higher doses of both substances (20 ,uM), neither viral synthesis nor precursor accumulation of the same viral proteins was discerned ( Complete inhibition of viral protein synthesis was observed when compounds 3a and 3b were added at the time of virus inoculation and maintained throughout the entire incubation period (6 h, 37°C) (Fig. 3A and B, lanes d and d') . The inhibitory effect was completely lost when compounds were added immediately after virus adsorption (0 time) or later (lanes e, e', f, f', g, g', h, h', i, and i'). The presence of the compounds during the viral adsorption period only (30 min, 37°C) was also sufficient to entirely suppress viral protein synthesis (lanes c and c'), indicating that their action was effected in the early stage(s) of infection.
Poliovirus protein synthesis was also fully prevented when cell cultures were pretreated with compounds (20 FM, 30 min, 37°C) before infection (Fig. 3C ).
Effect of compounds 3a and 3b on poliovirus RNA synthesis.
To study the effect of compounds 3a and 3b on viral RNA synthesis, the kinetics of [5,6-3H] uridine incorporation in the presence of actinomycin D to prevent cellular RNA synthesis was measured in infected and mock-infected cells.
When 20,uM compound 3a or 3b was added at the beginning of infection, the viral RNA synthesis was significantly reduced (by 50 to 60% at the third hour after infection) ( Fig. 4A and B). The inhibitory action is considered to be dose dependent, since no effect was observed at the 2 ,uM concentration ( Fig. 4A and B) . When the compounds were added after virus adsorption or later, no inhibitory effect was observed (Fig. 4C) (Table 2 ).
The effect of drugs on viral uncoating was measured as the remaining TCA-precipitable materials after treatment of cell lysates with RNase to digest free viral RNA. Neither compound had an effect on the viral uncoating ( Table 2) .
Effect of compounds 3a and 3b on poliovirus infectious titer and heat inactivation of virus infectivity. At the inhibitory concentration in cell cultures (20 ,uM), compounds 3a and 3b neither reduced the poliovirus infectious titer, even after a 60-min incubation at 37°C, nor stabilized the virus infectivity against heat inactivation at 56°C for 20 min (data not shown). Effect of compounds 3a and 3b on free viral RNA. Since compounds 3a and 3b did not appear to act on the uncoating of the viral genome, it was of interest to determine whether the compounds would affect the infectivity of free viral RNA under similar conditions.
Monolayers of HEp-2 cells in 35-mm plastic dishes were treated with DEAE-dextran and infected with phenol-extracted poliovirus RNA in the presence or absence of different concentrations of compounds 3a and 3b; the viral yield was measured as described in Materials and Methods.
At a 20 p,M concentration, compounds 3a and 3b significantly reduced the viral replication (by about 80%o), whereas no inhibition was observed at a 2 pM concentration for either drug (Table 2) .
DISCUSSION
In previous reports (4, 13) , we demonstrated that the halogenated isofiavans and 3(21H)-isofiavenes under study exhibited a significant inhibitory effect against rhinovirus 1B and hepatitis A virus infection in cell cultures. Results presented here indicate that the activity of some of these drugs extends also to poliovirus type 2 infection in vitro, although at higher doses the drugs inhibit both plaque formation and viral CPE. The related compound dichloroflavan was inactive on poliovirus type 2 replication (with the exception of one of the retromutant strains, which exhibited marginal susceptibility). This is in agreement with data found for poliovirus type 1 (2) . Thus, the studied compounds exhibit an expanded antiviral spectrum with respect to dichlorofiavan. Among the drugs tested, 3(2H)-isoflavene and 6-chloro-3(2H)-isoflavene were the most effective inhibitors of poliovirus type 2 infection. These findings are in contrast with those reported for infection with rhinovirus (6) and hepatitis A virus (13) , which exhibited a greater susceptibility to the action of isoflavans. Therefore, the planarity of the molecule of isoflavenes seems to be in direct correlation with the antiviral activity. The finding that compound 3b exhibited an antipoliovirus effect similar to that of compound 3a indicates that the presence of the chlorine atom in the 6 position also favored the antiviral activity. The shutoff of cellular protein synthesis in the presence of compounds 3a and 3b is consistent with the hypothesis that the translation of parental viral RNA is also prevented (9, 11, 12) .
Our results strongly suggest that an early step of the viral replication cycle may be selectively inhibited. Nevertheless, compounds 3a and 3b had no noticeable effect on viral attachment, penetration, and uncoating. Furthermore, both compounds reduced the infectivity of phenol-extracted viral RNA as effectively as they inhibited the replication of whole virions, and they did not protect the virus infectivity from heat inactivation, indicating that compounds could probably act immediately after the uncoating step. However, it cannot be conclusively excluded that uncoating of the virus genome is a possible target of compound(s) under study. As already suggested by Tisdale and Selway (15) , the measurement of uncoating as RNase sensitivity of the isotopically labeled viral nucleic acid might be too insensitive because of the large number of uninfectious particles, which, entering the cells through an abortive pathway, may obscure the final result (10) . Taking into account that HRV and poliovirus infections are more susceptible to isoflavans and isoflavenes, respectively, we cannot rule out the involvement of different mechanisms of action for the antiviral activity of these two classes of compounds.
An interesting feature of these compounds is their capac- (6) . This characteristic makes these substances suitable for further in vivo studies.
